Related Experiment Videos
Treatment of multiple sclerosis with various interferons: the cons
1Department of Neurology, University of Maryland Hospital, Baltimore 21201.
Neurology
|July 1, 1988
Summary
Recombinant gamma interferon is not suitable for treating multiple sclerosis (MS). While other interferons are used, this pilot study found gamma interferon ineffective for MS therapy.
Area of Science:
- Immunology
- Neuroscience
- Biotherapy
Background:
- Alpha and beta interferons are established, low-toxicity treatments for multiple sclerosis (MS).
- Interferons are human gene products with therapeutic applications.
Purpose of the Study:
- To evaluate the efficacy of recombinant gamma interferon as a therapy for multiple sclerosis (MS).
Main Methods:
- A pilot study involving 18 patients with multiple sclerosis.
- Treatment with recombinant gamma interferon.
Main Results:
- Recombinant gamma interferon treatment showed unsuitability for MS therapy.
- The study indicated negative outcomes or lack of efficacy.
Conclusions:
- Recombinant gamma interferon is not a viable therapeutic option for multiple sclerosis based on this pilot study.
- Further research into interferon-based therapies for MS should focus on alternative forms.